ED
FXI icon

Exane Derivatives’s iShares China Large-Cap ETF FXI Stock Holding History

Exane Derivatives’s Portfolio FXI Stock Details FXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$305 Sell
9
-3
-25% -$94 ﹤0.01% 638
2022
Q1 		$384 Sell
12
-36,449
-100% -$1.29M ﹤0.01% 898
2021
Q4 		$1.33M Buy
36,461
+12,201
+50% +$479K 0.32% 63
2021
Q3 		$944K Buy
24,260
+10,308
+74% +$426K 0.23% 97
2021
Q2 		$621K Buy
13,952
+158
+1% +$7.29K 0.14% 143
2021
Q1 		$644K Buy
13,794
+301
+2% +$14.9K 0.18% 119
2020
Q4 		$626K Sell
13,493
-940
-7% -$42.9K 0.18% 117
2020
Q3 		$606K Sell
14,433
-4,442
-24% -$191K 0.18% 115
2020
Q2 		$749K Sell
18,875
-6,784
-26% -$265K 0.2% 102
2020
Q1 		$963K Buy
25,659
+9,640
+60% +$392K 0.27% 82
2019
Q4 		$714K Sell
16,019
-13,387
-46% -$558K 0.13% 122
2019
Q3 		$1.17M Sell
29,406
-3,695
-11% -$150K 0.21% 93
2019
Q2 		$1.42M Sell
33,101
-8,768
-21% -$375K 0.25% 84
2019
Q1 		$1.85M Sell
41,869
-15,889
-28% -$678K 0.37% 75
2018
Q4 		$2.26M Buy
57,758
+19,681
+52% +$795K 0.41% 73
2018
Q3 		$1.63M Buy
38,077
+25,953
+214% +$1.1M 0.31% 82
2018
Q2 		$521K Sell
12,124
-4,721
-28% -$221K 0.09% 178
2018
Q1 		$786K Sell
16,845
-880,674
-98% -$43.3M 0.16% 134
2017
Q4 		$41.4M Buy
897,519
+151,550
+20% +$7M 7.14% 1
2017
Q3 		$32.8M Buy
745,969
+164,176
+28% +$7.04M 6.14% 4
2017
Q2 		$23.1M Sell
581,793
-186,378
-24% -$7.31M 4.96% 4
2017
Q1 		$29.6M Buy
768,171
+74,747
+11% +$2.82M 6.69% 2
2016
Q4 		$24.1M Buy
693,424
+282,421
+69% +$10.4M 4.75% 4
2016
Q3 		$15.6M Sell
411,003
-354,820
-46% -$13M 2.34% 5
2016
Q2 		$26.2M Buy
765,823
+318,977
+71% +$10.6M 4.33% 1
2016
Q1 		$15.1M Buy
446,846
+22,939
+5% +$720K 2% 4
2015
Q4 		$15M Buy
423,907
+253,155
+148% +$9.52M 2.05% 24
2015
Q3 		$6.06M Sell
170,752
-102,672
-38% -$3.99M 0.77% 40
2015
Q2 		$12.6M Buy
273,424
+116,905
+75% +$5.79M 1.36% 33
2015
Q1 		$6.95M Sell
156,519
-152,130
-49% -$6.48M 0.77% 39
2014
Q4 		$12.8M Buy
+308,649
New +$12.2M 1.78% 23

Other funds holding FXI

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Exane Derivatives's FXI Position: Q2 2022 in Review

Exane Derivatives reduced its iShares China Large-Cap ETF (FXI) stake by 25% in Q2 2022, selling an estimated $94 and leaving 9 shares worth $305. The position accounts for ﹤0.01% of the portfolio, ranked #638.

Exane Derivatives first reported a position in FXI in Q4 2014 and has held it in 31 quarters since. The position peaked at $41.4M in Q4 2017. 283 funds tracked by Wall St. Rank hold FXI as of Q2 2022.

  • Exane Derivatives held 9 shares of iShares China Large-Cap ETF worth $305 as of Q2 2022.
  • Exane Derivatives sold 3 iShares China Large-Cap ETF shares in Q2 2022, an estimated $94.
  • iShares China Large-Cap ETF made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #638 holding.
  • Exane Derivatives first reported a position in iShares China Large-Cap ETF in Q4 2014 and has held it in 31 quarters since.
  • Exane Derivatives's iShares China Large-Cap ETF position peaked at $41.4M in Q4 2017.
  • 283 funds tracked by Wall St. Rank held iShares China Large-Cap ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.